Printer Friendly
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary
3,910,006,575 visitors served.
forum Join the Word of the Day Mailing List For webmasters
?
Dictionary/
thesaurus
Medical
dictionary
Legal
dictionary
Financial
dictionary
Acronyms
 
Idioms
Encyclopedia
Wikipedia
encyclopedia
?

drotrecogin alfa

   Also found in: Dictionary/thesaurus, Wikipedia 0.02 sec.
drotrecogin alfa,
a thrombolytic agent used to treat severe sepsis associated with organ dysfunction.

drotrecogin alfa (activated) Warning - High-alert drug!

Xigris

Pharmacologic class: Activated protein C (recombinant)

Therapeutic class: Antisepsis drug

Pregnancy risk category C

Action

Antisepsis action unknown. May produce indirect profibrinolytic activity by hindering plasminogen activator inhibitor-1 and limiting generation of activated thrombin-activatable fibrinolysis inhibitor. Produces anti-inflammatory effect by inhibiting human tumor necrosis factor production and suppressing thrombin-induced inflammatory responses.

Availability

Powder for injection (lyophilized): 5 mg, 20 mg

Indications and dosages

Severe sepsis

Adults: 24 mcg/kg/hour I.V. for a total duration of 96 hours

Contraindications

• Hypersensitivity to drug or its components
• Intracranial neoplasm or lesion or evidence of cerebral herniation
• Intracranial or intraspinal surgery within past 2 months
• Hemorrhagic stroke within past 3 months
• Severe head trauma or trauma with increased risk of bleeding
• Active bleeding or high risk of bleeding
• Patients undergoing bone marrow therapy
• Current use of epidural catheter

Precautions

Use cautiously in:
• intracranial arteriovenous malformation, chronic severe hepatic disease, recent GI bleeding
• concurrent use of heparin, thrombolytics, oral anticoagulants, or aspirin
• pregnant patients
• children (safety and efficacy not established).

Administration

• Mix with normal saline solution, lactated Ringer's solution, or dextrose 5% in water.
• Prepare immediately before use. Hang infusion bag within 3 hours of reconstitution; complete infusion within 12 hours after preparation.
• Administer only through infusion pump.
• Don't infuse with any other drug.
• Give entire regimen over 96 hours.
Discontinue drug 2 hours before invasive procedures.
• Be aware that once hemostasis occurs, drug therapy may resume immediately after uncomplicated invasive procedures or 12 hours after major invasive procedures (such as surgery).

RouteOnsetPeakDuration
I.V.RapidUnknownUnknown

Adverse reactions

CNS: intracranial hemorrhage

GI: intra-abdominal, retroperitoneal, or other GI tract bleeding

GU: bleeding

Hematologic: bleeding

Skin: bruising

Other: skin and soft-tissue bleeding, intrathoracic bleeding

Interactions

Drug-drug. Anticoagulants, aspirin, glycoprotein IIb/IIIa inhibitors, indomethacin, phenylbutazone, thrombolytics: increased risk of bleeding

Drug-diagnostic tests. Activated partial thromboplastin time (APTT), prothrombin time (PT): prolonged

Hematocrit: decreased

Patient monitoring

Know that no antidote exists. Monitor closely for signs and symptoms of hemorrhage. Stop infusion if clinically significant bleeding occurs.
• Monitor PT and CBC (especially platelet count).
• Realize that drug may variably prolong APTT and thus doesn't reliably indicate coagulopathy.

Patient teaching

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and tests mentioned above.



Want to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit the webmaster's page for free fun content.
?Page tools
Printer friendly
Cite / link
Feedback
Add definition
Mentioned in?  References in periodicals archive?   Medical browser?   Full browser?
 
7) The 24-hour sepsis management bundle includes the use of low-dose corticosteroids for septic shock patients who manifest decreased adrenal function as defined by their ICU policy, glycemic control, lung protective ventilatory support strategies, and prudent use of drotrecogin alfa (activated) according to institutional policy.
Eli Lilly and Company (NYSE:LLY), Indianapolis, has announced that the Federal Food and Drug Administration has extended the action date for the completion of its review of the biologics license application (BLA) for drotrecogin alfa (activated) for the treatment of severe sepsis from July 27 to Oct.
While drotrecogin alfa (DA) has been employed in patients with Methicillin-resistant Staphylococcus aureus (MRSA) severe sepsis and septic shock, its utility in TSS remains unclear.
 
 
 
Medical Dictionary
?

Terms of Use | Privacy policy | Feedback | Advertise with Us | Copyright © 2012 Farlex, Inc.
Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.